TY - JOUR
TI - The personalized medicine and the pharmacogenomics in treatment of central nervous system diseases - future of pharmacotherapy or next challenge for a health care system?
AU - Bochenek, Tomasz
AU - Lasoń, Władysław
TI - The personalized medicine and the pharmacogenomics in treatment of central nervous system diseases - future of pharmacotherapy or next challenge for a health care system?
AB - The concept of personalized medicine has become increasingly popular and even “fashionable” within recent years, although the idea of personalization had originated in medicine much earlier than it gained its current label. Providing a therapy which is tailored to needs of a particular patient has been facilitated in selected areas of medicine by successful translation of the human genome and the developments of modern diagnostics and pharmacology. The personalized medicine is an area of development of medical and social sciences. It is also taking position within the health care system and it requires the sound sources of financing. The authors analyze the current status of knowledge on personalized medicine from the health care system’s point of view and setting the special focus on diseases of the central nervous system, including epilepsy. The on-going R&D initiatives from the field of the pharmacogenomics and the personalized medicine have been also presented in this paper
VL - 2013
IS - Volume 11, Issue 1
PY - 2013
SN - 1731-7398
C1 - 2084-2627
SP - 59
EP - 68
DO - 10.4467/20842627OZ.14.006.1616
UR - https://ejournals.eu/en/journal/zdrowie-publiczne-i-zarzadzanie/article/medycyna-zindywidualizowana-i-farmakogenomika-w-leczeniu-schorzen-centralnego-ukladu-nerwowego-przyszlosc-farmakoterapii-czy-kolejne-wyzwanie-dla-systemu-opieki-zdrowotnej
KW - central nervous system
KW - epilepsy
KW - genetic diagnostics
KW - health care system
KW - personalized medicine
KW - pharmacogenomics
KW - pharmacogenetics
KW - pharmaceuticals